Sex Subgroup Analysis of Treatment Response to Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years With Attention-Deficit/Hyperactivity Disorder

被引：0
|
作者：
McGough, James J. [1 ,2 ]
Greenbaum, Michael [3 ]
Adeyi, Ben [4 ]
Babcock, Thomas [4 ]
Scheckner, Brian [4 ]
Dirks, Bryan [4 ]
Findling, Robert L. [5 ]
机构：
[1] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] Capstone Clin Res, Libertyville, IL USA
[4] Shire Dev Inc, Wayne, PA USA
[5] Univ Hosp Case Med Ctr, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2012年 / 32卷 / 01期
关键词：
CLINICAL-TRIALS; MODERATORS; ADHD;
D O I：
10.1097/JCP.0b013e318240dc53
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：138 / 140
页数：4
相关论文
共 50 条
  • [21] Lisdexamfetamine for Treatment of Attention-Deficit/Hyperactivity Disorder
    Cowles, Brian J.
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (04) : 669 - 676
  • [22] A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK
    Zimovetz, Evelina A.
    Joseph, Alain
    Ayyagari, Rajeev
    Mauskopf, Josephine A.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2018, 19 (01): : 21 - 35
  • [23] Review of lisdexamfetamine dimesylate in children and adolescents with attention deficit/hyperactivity disorder
    Najib, Jadwiga
    Didenko, Ekaterina
    Meleshkina, Daria
    Yusupov, Kamila
    Maw, Kateryna
    Ramnarain, Justin
    Tabassum, Maliha
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (10) : 1717 - 1735
  • [24] A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK
    Evelina A. Zimovetz
    Alain Joseph
    Rajeev Ayyagari
    Josephine A. Mauskopf
    The European Journal of Health Economics, 2018, 19 : 21 - 35
  • [25] Long-term effectiveness and safety of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder
    Findling, Robert L.
    Childress, Ann C.
    Krishnan, Suma
    McGough, James J.
    CNS SPECTRUMS, 2008, 13 (07) : 614 - 620
  • [26] Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use
    Rakesh Jain
    Thomas Babcock
    Teodor Burtea
    Bryan Dirks
    Ben Adeyi
    Brian Scheckner
    Robert Lasser
    John Renna
    Don Duncan
    Advances in Therapy, 2013, 30 : 472 - 486
  • [27] Patterns of Lisdexamfetamine Dimesylate Use in Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder in Europe
    Siffel, Csaba
    Page, Matthew
    Maxwell, Tricia
    Thun, Barbara
    Kolb, Nikolaus
    Rosenlund, Mats
    von Bredow, Dorothea
    Keja, Jacco
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020, 30 (07) : 439 - 447
  • [28] Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use
    Jain, Rakesh
    Babcock, Thomas
    Burtea, Teodor
    Dirks, Bryan
    Adeyi, Ben
    Scheckner, Brian
    Lasser, Robert
    Renna, John
    Duncan, Don
    ADVANCES IN THERAPY, 2013, 30 (05) : 472 - 486
  • [29] Treatment Outcomes with Lisdexamfetamine Dimesylate in Children Who Have Attention-Deficit/Hyperactivity Disorder with Emotional Control Impairments
    Katic, Alain
    Dirks, Bryan
    Babcock, Thomas
    Scheckner, Brian
    Adeyi, Ben
    Richards, Cynthia
    Findling, Robert L.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2013, 23 (06) : 386 - 393
  • [30] EFFICACY OF LISDEXAMFETAMINE DIMESYLATE IN CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: EFFECT OF AGE, SEX AND BASELINE DISEASE SEVERITY
    Lecendreux, M.
    Banaschewski, T.
    Soutullo, C.
    Johnson, M.
    Zuddas, A.
    Anderson, C.
    Civil, R.
    Higgins, N.
    Bloomfield, R.
    Squires, L.
    Coghill, D.
    EUROPEAN PSYCHIATRY, 2013, 28
12345